Literature DB >> 10981161

Effects of antihypertensive therapy on hypertensive vascular disease.

J B Park1, E L Schiffrin.   

Abstract

Hypertension is associated with alterations in the structure, function, and mechanical properties of large and small arteries. Changes in the endothelium, smooth muscle cell, extracellular matrix, and possibly the adventitia, contribute to complications of hypertension. In large arteries, vascular hypertrophy is found, often with increased stiffness of media components. In small arteries, particularly in mild hypertension, rearrangement of smooth muscle cells around a smaller lumen without changes in media volume (eutrophic remodeling) occurs; in more severe hypertension, hypertrophic remodeling with increased vascular stiffness can be found. Vascular remodeling is accompanied by an increase in the extracellular matrix, particularly collagen deposition. Recent studies have demonstrated that vascular remodeling and endothelial dysfunction of small and large vessels may be normalized by treatment with some antihypertensive agents (angiotensin converting enzyme inhibitors, angiotensin AT(1) receptor antagonists, and long-acting calcium channel blockers). Angiotensin converting enzyme inhibitors have now been shown to improve outcomes in hypertensive patients, an effect that may in part be related to the vascular protective effects reviewed here.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10981161     DOI: 10.1007/s11906-000-0011-5

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  109 in total

1.  Mortality amongst patients of the Glasgow Blood Pressure Clinic was high in the 1970s and 80s but has fallen since, why?

Authors:  A F Lever; D G Beevers; D J Hole; C G Isles; P A Meredith; L S Murray; G T McInnes; J L Reid
Journal:  Clin Exp Hypertens       Date:  1999 Jul-Aug       Impact factor: 1.749

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Presence of cardiovascular structural changes in essential hypertensive patients with coronary microvascular disease and effects of long-term treatment.

Authors:  A Virdis; L Ghiadoni; A Lucarini; V Di Legge; S Taddei; A Salvetti
Journal:  Am J Hypertens       Date:  1996-04       Impact factor: 2.689

4.  Vascular endothelin-1 expression and effect of an endothelin ETA antagonist on structure and function of small arteries from stroke-prone spontaneously hypertensive rats.

Authors:  A M Sharifi; G He; R M Touyz; E L Schiffrin
Journal:  J Cardiovasc Pharmacol       Date:  1998       Impact factor: 3.105

5.  Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta-blocker.

Authors:  E L Schiffrin; L Y Deng; P Larochelle
Journal:  Am J Hypertens       Date:  1995-03       Impact factor: 2.689

Review 6.  Small artery structure in hypertension. Dual processes of remodeling and growth.

Authors:  A M Heagerty; C Aalkjaer; S J Bund; N Korsgaard; M J Mulvany
Journal:  Hypertension       Date:  1993-04       Impact factor: 10.190

7.  Value of ambulatory intra-arterial blood pressure monitoring in the long-term prediction of left ventricular hypertrophy and carotid atherosclerosis in essential hypertension.

Authors:  R S Khattar; R Senior; J D Swales; A Lahiri
Journal:  J Hum Hypertens       Date:  1999-02       Impact factor: 3.012

8.  Dose-dependent effects of perindopril on blood pressure and small-artery structure.

Authors:  N K Thybo; N Korsgaard; S Eriksen; K L Christensen; M J Mulvany
Journal:  Hypertension       Date:  1994-05       Impact factor: 10.190

9.  Prevalence and determinants of cardiac and vascular hypertrophy in hypertension.

Authors:  M J Roman; T G Pickering; R Pini; J E Schwartz; R B Devereux
Journal:  Hypertension       Date:  1995-08       Impact factor: 10.190

10.  Aortic distensibility and structural changes in sinoaortic-denervated rats.

Authors:  P Lacolley; Y Bezie; X Girerd; P Challande; A Benetos; P Boutouyrie; N Ghodsi; B Lucet; R Azoui; S Laurent
Journal:  Hypertension       Date:  1995-08       Impact factor: 10.190

View more
  6 in total

1.  Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice.

Authors:  Modar Kassan; Maria Galan; Megan Partyka; Mohamed Trebak; Khalid Matrougui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 2.  Angiotensin and cytoskeletal proteins: role in vascular remodeling.

Authors:  Jos P M Wesselman; Jo G R De Mey
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

Review 3.  Small artery remodeling in hypertension.

Authors:  Michael J Mulvany
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

4.  Soluble receptor for advanced glycation end products mitigates vascular dysfunction in spontaneously hypertensive rats.

Authors:  Yu Liu; Manli Yu; Le Zhang; Qingxin Cao; Ying Song; Yuxiu Liu; Jianbin Gong
Journal:  Mol Cell Biochem       Date:  2016-07-18       Impact factor: 3.396

Review 5.  Factors influencing the systolic blood pressure response to drug therapy.

Authors:  Carlos Campo; Julián Segura; Luis M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Jan-Feb       Impact factor: 3.738

6.  Salvia fruticosa Induces Vasorelaxation In Rat Isolated Thoracic Aorta: Role of the PI3K/Akt/eNOS/NO/cGMP Signaling Pathway.

Authors:  M Akhtar Anwar; Ali A Samaha; Samar Ballan; Alaaeldin I Saleh; Rabah Iratni; Ali H Eid
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.